(VIANEWS) – SCATEC (SCATC.OL), GECINA (GFC.PA), GUERBET (GBT.PA) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio up to now. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. SCATEC (SCATC.OL)
923.81% Payout Ratio
Scatec ASA, together with its subsidiaries, provides renewable energy solutions worldwide. The company operates through Power Production; Services; and Development & Construction segments. It develops, builds, owns, and operates solar, wind, and hydro power plants and storage solutions. The company is also involved in the engineering, procurement, construction, operation, maintenance, and asset management of power plants. It has a total of 4.6 GW in operation and under construction. The company was formerly known as Scatec Solar ASA and changed its name to Scatec ASA in November 2020. Scatec ASA was incorporated in 2007 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, SCATEC has a trailing twelve months EPS of kr-1.11.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.35%.
Moving Average
SCATEC’s worth is way higher than its 50-day moving average of kr65.49 and way above its 200-day moving average of kr70.09.
More news about SCATEC.
2. GECINA (GFC.PA)
231.44% Payout Ratio
As a specialist for centrality and uses, Gecina operates innovative and sustainable living spaces. The Group owns, manages and develops Europe's leading office portfolio, with nearly 97% located in the Paris Region, and a portfolio of residential assets and student residences, with over 9,000 apartments. These portfolios are valued at 18.5 billion euros at end-June 2023. Gecina has firmly established its focus on innovation and its human approach at the heart of its strategy to create value and deliver on its purpose: “Empowering shared human experiences at the heart of our sustainable spaces”. For our 100,000 clients, this ambition is supported by our client-centric brand YouFirst. It is also positioned at the heart of UtilesEnsemble, our program setting out our solidarity-based commitments to the environment, to people and to the quality of life in cities. Gecina is a French real estate investment trust (SIIC) listed on Euronext Paris, and is part of the SBF 120, CAC Next 20, CAC Large 60 and CAC 40 ESG indices. Gecina is also recognized as one of the top-performing companies in its industry by leading sustainability benchmarks and rankings (GRESB, Sustainalytics, MSCI, ISS-ESG and CDP).
Earnings Per Share
As for profitability, GECINA has a trailing twelve months EPS of €-13.55.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.05%.
Moving Average
GECINA’s value is way higher than its 50-day moving average of €95.57 and way above its 200-day moving average of €99.11.
Yearly Top and Bottom Value
GECINA’s stock is valued at €111.30 at 01:10 EST, under its 52-week high of €114.20 and way above its 52-week low of €87.00.
More news about GECINA.
3. GUERBET (GBT.PA)
85.86% Payout Ratio
Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution; Dotarem, a gadoteric acid-gadoterate meglumine, and Artirem, a gadoteric acid that acts as a contrast agent for MRI, as well as prefilled syringes, injectors, accessories, and consumables for MRI, CT, and Cath Lab. It also provides digital solutions, such as Contrast&Care, an injection management solution; Dose&Care, an X-ray dose management solution; and icobrain, a cloud-based AI solution to quantify disease-specific brain structures for acute and chronic neurological conditions on MR and CT, as well as OptiProtect services. In addition, the company provides products for interventional radiology, including Lipiodol ethyl esters of iodinated fatty acids of poppyseed oil; Vectorio, a mixing and injection system for conventional trans-arterial chemoembolization; Patent Blue V, a blue dye; Axessio, a peripheral micro guidewire; and SeQure and DraKon, which are microcatheters. Further, it offers Hydra Vision, a digital imaging system for urological, gastroenterological, and gynecological treatment, as well as planning and diagnostic procedures; and urology accessories and consumables. The company was incorporated in 1926 and is headquartered in Villepinte, France.
Earnings Per Share
As for profitability, GUERBET has a trailing twelve months EPS of €-3.35.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.79%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jun 29, 2023, the estimated forward annual dividend rate is 0.5 and the estimated forward annual dividend yield is 2.97%.
More news about GUERBET.
4. ERAMET (ERA.PA)
39.46% Payout Ratio
ERAMET S.A. operates as a mining and metallurgical company in France, Asia, Europe, North America, and internationally. The company extracts and processes manganese ore and nickel ore; and extracts and develops mineral sands. It also produces ferronickel, nickel pig iron, briquettes, nickel salts, high purity nickel, nickel ferroalloys, and alloy steel and casting; manganese alloys, such as high-carbon ferromanganese, silicomanganese, low and medium-carbon ferromanganese, and low-carbon silicomanganese for use in batteries, pigments, construction, and automotive industries; and mineral sands, such as titanium dioxide, high-purity pig iron, zircon, and ilmenite used in ceramics and pigments. In addition, it operates Moanda mine in Gabon; nickel mines in New Caledonia and Indonesia; and mineral sand mine in Senegal and Argentina. ERAMET S.A. was incorporated in 1880 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, ERAMET has a trailing twelve months EPS of €8.87.
PE Ratio
ERAMET has a trailing twelve months price to earnings ratio of 8.16. Meaning, the purchaser of the share is investing €8.16 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.28%.
More news about ERAMET.
5. SAVENCIA (SAVE.PA)
36.11% Payout Ratio
Savencia SA produces, distributes, and markets dairy and cheese products in France, rest of Europe, and internationally. It offers cheese, butters, creams, and dairy ingredients and nutritional solutions for the retail market and foodservices market. The company provides its products under the Caprice des Dieux, Saint Albray, Le Rustique, Cœur de Lion, Saint Agur, Bresse Bleu, PDO Roquefort Papillon, St-Morêt, Tartare, Carré Frais, Apérivrais, Chavroux, Saint-Loup, RichesMonts raclette, Géramont, Saint Albray, Fol Epi, Bresso, Milkana, Brunch, Burgo de Arias, Ile de France, Milkaut, Santa Rosa, Delaco, Kral Syru, Lucina, Král Sýru, Medve, Alouette, Rogue Creamery, Polenghi, Corman, Balade, and Elle & Vire brands. The company was formerly known as Bongrain SA and changed its name to Savencia SA in April 2015.Savencia SA was founded in 1956 and is headquartered in Viroflay, France. Savencia SA operates as a subsidiary of Savencia Holding.
Earnings Per Share
As for profitability, SAVENCIA has a trailing twelve months EPS of €3.6.
PE Ratio
SAVENCIA has a trailing twelve months price to earnings ratio of 14.67. Meaning, the purchaser of the share is investing €14.67 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.33%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 15, 2023, the estimated forward annual dividend rate is 1.3 and the estimated forward annual dividend yield is 2.43%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.7%, now sitting on 6.9B for the twelve trailing months.
Volume
Today’s last reported volume for SAVENCIA is 296 which is 93.71% below its average volume of 4711.
More news about SAVENCIA.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
1’s EBITDA is 1.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, 1’s stock is considered to be overbought (>=80).
Volatility
1’s last week, last month’s, and last quarter’s current intraday variation average was 1.00%, 1.00%, and 1.00%.
1’s highest amplitude of average volatility was 1.00% (last week), 1.00% (last month), and 1.00% (last quarter).
More news about 1.
